• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物在脑血管痉挛中的作用。

Role of statins in cerebral vasospasm.

作者信息

Sugawara T, Ayer R, Zhang J H

机构信息

Department of Physiology and Pharmacology, Loma Linda University Medical School, Loma Linda, California 92354, USA.

出版信息

Acta Neurochir Suppl. 2008;104:287-90. doi: 10.1007/978-3-211-75718-5_59.

DOI:10.1007/978-3-211-75718-5_59
PMID:18457003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2743544/
Abstract

3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, commonly known as statins, are widely used clinically for their lipid lowering properties. Recent evidence shows that statins are also effective in ameliorating cerebral vasospasm, which occurs as sequelae of subarachnoid haemorrhage. This review focuses on the pleiotropic effects of statins, and the putative mechanisms involved in statin mediated attenuation of cerebral vasospasm.

摘要

3-羟基-3-甲基戊二酰辅酶A(HMG辅酶A)还原酶抑制剂,通常被称为他汀类药物,因其降脂特性而在临床上被广泛使用。最近的证据表明,他汀类药物在改善蛛网膜下腔出血后遗症——脑血管痉挛方面也有效。这篇综述重点关注他汀类药物的多效性作用,以及他汀类药物介导减轻脑血管痉挛的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da73/2743544/84bafa7954be/nihms115812f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da73/2743544/84bafa7954be/nihms115812f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da73/2743544/84bafa7954be/nihms115812f1.jpg

相似文献

1
Role of statins in cerebral vasospasm.他汀类药物在脑血管痉挛中的作用。
Acta Neurochir Suppl. 2008;104:287-90. doi: 10.1007/978-3-211-75718-5_59.
2
Mechanisms of statin treatment in cerebral vasospasm.他汀类药物治疗脑血管痉挛的机制。
Acta Neurochir Suppl. 2011;110(Pt 2):9-11. doi: 10.1007/978-3-7091-0356-2_2.
3
Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.他汀类药物治疗动脉瘤性蛛网膜下腔出血后的脑血管痉挛。
Ann Pharmacother. 2007 Dec;41(12):2019-23. doi: 10.1345/aph.1K301. Epub 2007 Nov 6.
4
Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.他汀类药物治疗对动脉瘤性蛛网膜下腔出血患者血管痉挛相关发病率和功能结局的影响:系统评价和荟萃分析。
J Neurosurg. 2017 Aug;127(2):291-301. doi: 10.3171/2016.5.JNS152900. Epub 2016 Oct 7.
5
Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase.辛伐他汀通过增加Akt和内皮型一氧化氮合酶的磷酸化减轻大鼠蛛网膜下腔出血后的脑血管痉挛。
J Neurosci Res. 2008 Dec;86(16):3635-43. doi: 10.1002/jnr.21807.
6
Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.辛伐他汀可增加内皮型一氧化氮合酶,并改善蛛网膜下腔出血所致的脑血管痉挛。
Stroke. 2002 Dec;33(12):2950-6. doi: 10.1161/01.str.0000038986.68044.39.
7
Therapeutically Targeting Platelet-Derived Growth Factor-Mediated Signaling Underlying the Pathogenesis of Subarachnoid Hemorrhage-Related Vasospasm.治疗性靶向蛛网膜下腔出血相关血管痉挛发病机制中血小板衍生生长因子介导的信号传导
J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2289-2295. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.017. Epub 2018 Jul 20.
8
Evidence-based pharmacotherapy for cerebral vasospasm.基于证据的脑血管痉挛药物治疗
Neurol Res. 2009 Jul;31(6):615-20. doi: 10.1179/174313209X382377. Epub 2008 Dec 23.
9
Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats.阿托伐他汀预处理可减少内皮素-1 的产生,并预防大鼠实验性血管痉挛。
Acta Neurochir (Wien). 2010 Aug;152(8):1399-406; discussion 1405-6. doi: 10.1007/s00701-010-0652-3. Epub 2010 May 4.
10
Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.他汀类药物治疗对动脉瘤性蛛网膜下腔出血患者血管痉挛、迟发性脑缺血和功能结局的影响:系统评价和荟萃分析更新。
Stroke. 2010 Jan;41(1):e47-52. doi: 10.1161/STROKEAHA.109.556332. Epub 2009 Oct 29.

引用本文的文献

1
Effect of Statin Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of 1464 Patients.他汀类药物治疗对动脉瘤性蛛网膜下腔出血患者神经学转归的影响:对1464例患者的荟萃分析
BMC Neurol. 2025 Aug 25;25(1):349. doi: 10.1186/s12883-025-04286-2.
2
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.Rho 激酶抑制减轻了小鼠侵袭性 Pdcd10/Ccm3 疾病模型中的病变发展和出血。
Stroke. 2019 Mar;50(3):738-744. doi: 10.1161/STROKEAHA.118.024058.
3
High-Dose Simvastatin Is Effective in Preventing Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study in Korean Patients.大剂量辛伐他汀可有效预防动脉瘤性蛛网膜下腔出血后的脑血管痉挛:一项针对韩国患者的前瞻性队列研究。
J Korean Neurosurg Soc. 2015 Oct;58(4):328-33. doi: 10.3340/jkns.2015.58.4.328. Epub 2015 Oct 30.
4
Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.他汀类药物对动脉瘤性蛛网膜下腔出血患者的影响:一项随机对照试验的荟萃分析
Sci Rep. 2014 Apr 25;4:4573. doi: 10.1038/srep04573.
5
Statins in the critically ill.危重症患者的他汀类药物治疗。
Ann Intensive Care. 2012 Jun 18;2(1):19. doi: 10.1186/2110-5820-2-19.
6
Pleiotropic effects of the HMG-CoA reductase inhibitors.HMG-CoA 还原酶抑制剂的多效性作用。
Int J Gen Med. 2011 Apr 4;4:261-71. doi: 10.2147/IJGM.S16779.
7
Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.他汀类药物在动脉瘤性蛛网膜下腔出血患者管理中的应用:系统评价和荟萃分析。
Neurocrit Care. 2010 Apr;12(2):285-96. doi: 10.1007/s12028-009-9306-9.

本文引用的文献

1
Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience.他汀类药物治疗降低蛛网膜下腔出血后脑血管痉挛风险:一项机构经验的多变量分析
J Neurosurg. 2006 Nov;105(5):671-4. doi: 10.3171/jns.2006.105.5.671.
2
Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells.他汀类药物通过抑制培养的系膜细胞中NAD(P)H氧化酶的活性,减弱高糖诱导和血管紧张素II诱导的丝裂原活化蛋白激酶活性。
Med Chem. 2005 Sep;1(5):461-6. doi: 10.2174/1573406054864052.
3
Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.蛛网膜下腔出血后持续输注CGS 35066对基底动脉血管痉挛及超微结构改变的预防和逆转作用
Exp Biol Med (Maywood). 2006 Jun;231(6):1069-74.
4
Reactive oxygen species in vascular wall.血管壁中的活性氧物质。
Cardiovasc Hematol Disord Drug Targets. 2006 Mar;6(1):1-19. doi: 10.2174/187152906776092659.
5
Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.实验性蛛网膜下腔出血发作后全身给予辛伐他汀可减轻脑血管痉挛。
Neurosurgery. 2006 May;58(5):945-51; discussion 945-51. doi: 10.1227/01.NEU.0000210262.67628.7E.
6
Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.瑞舒伐他汀治疗可保护eNOS基因敲除小鼠免受硝酸盐诱导的氧化应激:NAD(P)H氧化酶途径的影响
Br J Pharmacol. 2006 Jun;148(4):544-52. doi: 10.1038/sj.bjp.0706738. Epub 2006 Apr 24.
7
Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.靶向Rho和Rho激酶治疗心血管疾病。
Trends Pharmacol Sci. 2006 Feb;27(2):97-104. doi: 10.1016/j.tips.2005.12.002. Epub 2005 Dec 27.
8
Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production.瑞舒伐他汀通过抑制NAD(P)H氧化酶依赖性超氧化物生成来改善Zucker肥胖大鼠的脑血管功能。
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1264-70. doi: 10.1152/ajpheart.00804.2005. Epub 2005 Nov 11.
9
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.辛伐他汀可降低动脉瘤性蛛网膜下腔出血后的血管痉挛:一项初步随机临床试验的结果
Stroke. 2005 Sep;36(9):2024-6. doi: 10.1161/01.STR.0000177879.11607.10. Epub 2005 Jul 28.
10
Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial.普伐他汀急性治疗对动脉瘤性蛛网膜下腔出血后脑血管痉挛、自动调节及迟发性缺血性神经功能缺损的影响:一项II期随机安慰剂对照试验
Stroke. 2005 Aug;36(8):1627-32. doi: 10.1161/01.STR.0000176743.67564.5d.